{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:08:50Z","timestamp":1793239730435,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH102215-02S2"],"award-info":[{"award-number":["R01 MH102215-02S2"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.schres.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T01:45:02Z","timestamp":1758159902000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype"],"prefix":"10.1016","volume":"285","author":[{"given":"Sonja","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristus","family":"Nwulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s002130051008","article-title":"Circadian rhythm of white blood cells during clozapine treatment","volume":"144","author":"Ahokas","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2025.09.011_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2022.02.009","article-title":"Re-examining the utility and validity of benign ethnic neutropenia: a narrative literature review","volume":"253","author":"Andreou","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.09.011_bb0015","first-page":"1","article-title":"Genetic identification of undiagnosed benign ethnic neutropenia in patients receiving clozapine treatment","author":"Aziri","year":"2024","journal-title":"Br. J. Psychiatry"},{"issue":"5953","key":"10.1016\/j.schres.2025.09.011_bb0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bmj.1.5953.306","article-title":"Normal haematological values: sex difference in neutrophil count","volume":"1","author":"Bain","year":"1975","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.schres.2025.09.011_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230109147387","article-title":"Initiation of clozapine therapy in a patient with preexisting leukopenia: a discussion of the rationale of current treatment options","volume":"13","author":"Boshes","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2025.09.011_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2147\/nedt.2006.2.4.531","article-title":"Cognitive deficits and functional outcome in schizophrenia","volume":"2","author":"Bowie","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s44202-023-00071-9","article-title":"Living with schizophrenia: the role of interpersonal relationships","volume":"3","author":"Commey","year":"2023","journal-title":"Discov. Psychol."},{"key":"10.1016\/j.schres.2025.09.011_bb0040","first-page":"3","article-title":"Prevalence, phenotype and inheritance of benign neutropenia in Arabs","volume":"9","author":"Denic","year":"2009","journal-title":"BMC Blood Disord."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0045","first-page":"66","article-title":"Assessment of capacity to give consent to research participation: state-of-the-art and beyond","volume":"1","author":"DeRenzo","year":"1998","journal-title":"J. Health Care Law Policy"},{"issue":"4","key":"10.1016\/j.schres.2025.09.011_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036308","article-title":"Haematological and biochemical reference values for healthy adults in the middle belt of Ghana","volume":"7","author":"Dosoo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2025.09.011_bb0055","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"205","author":"Edition","year":"1980"},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psc.2009.12.003","article-title":"The role of genetics in the etiology of schizophrenia","volume":"33","author":"Gejman","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"issue":"12","key":"10.1016\/j.schres.2025.09.011_bb0065","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1080\/02664763.2019.1706725","article-title":"The multinomial logistic regression model for predicting the discharge status after liver transplantation: estimation and diagnostics analysis","volume":"47","author":"Hashimoto","year":"2020","journal-title":"J. Appl. Stat."},{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1176\/appi.ps.201200041","article-title":"The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries","volume":"64","author":"Horvitz-Lennon","year":"2013","journal-title":"Psychiatr. Serv."},{"issue":"7","key":"10.1016\/j.schres.2025.09.011_bb0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-146-7-200704030-00004","article-title":"Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences","volume":"146","author":"Hsieh","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.schres.2025.09.011_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ibanez","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12888-016-1167-0","article-title":"Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland","volume":"16","author":"Ingimarsson","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2025.09.011_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/JBM.S16214","article-title":"Subclinical leukopenia in a cross section of Nigerian blood donors","volume":"2","author":"Jeremiah","year":"2011","journal-title":"J. Blood Med."},{"issue":"9","key":"10.1016\/j.schres.2025.09.011_bb0095","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4088\/JCP.v67n0911","article-title":"Clozapine utilization and outcomes by race in a public mental health system: 1994-2000","volume":"67","author":"Kelly","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2025.09.011_bb0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.schres.2023.08.002","article-title":"Clozapine and neutrophil response in patients of African descent: a six-month, multinational, prospective, open-label clinical trial","volume":"268","author":"Kelly","year":"2024","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2025.09.011_bb0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamapsychiatry.2025.1155","article-title":"FDA eliminates the clozapine REMS: what comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41398-021-01322-w","article-title":"HLA-DQB1 6672G> C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry","volume":"11","author":"Konte","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2025.09.011_bb0115","first-page":"117","article-title":"Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics","volume":"9","author":"Lally","year":"2016","journal-title":"Pharmgenomics Pers. Med."},{"issue":"11","key":"10.1016\/j.schres.2025.09.011_bb0120","first-page":"1525","article-title":"Lithium carbonate and leukocytosis","volume":"37","author":"Lapierre","year":"1980","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.schres.2025.09.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116305","article-title":"The global burden of schizophrenia and the impact of urbanization during 1990\u20132019: an analysis of the global burden of disease study 2019","volume":"232","author":"Li","year":"2023","journal-title":"Environ. Res."},{"issue":"4","key":"10.1016\/j.schres.2025.09.011_bb0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.158.4.503","article-title":"The effects of clozapine on tardive dyskinesia","volume":"158","author":"Lieberman","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.09.011_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.schres.2017.08.041","article-title":"Sodium valproate and clozapine induced neutropenia: a case control study using register data","volume":"195","author":"Malik","year":"2018","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2025.09.011_bb0140","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ps.201100435","article-title":"Factors associated with initiation on clozapine and on other antipsychotics among Medicaid enrollees","volume":"63","author":"Manuel","year":"2012","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-3223(98)00377-1","article-title":"Smoking and therapeutic response to clozapine in patients with schizophrenia","volume":"46","author":"McEvoy","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2025.09.011_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"7","key":"10.1016\/j.schres.2025.09.011_bb0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.2020008600","article-title":"When non-whiteness becomes a condition","volume":"137","author":"Merz","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/bloodadvances.2022007679","article-title":"Absolute neutrophil count by Duffy status among healthy Black and African American adults","volume":"7","author":"Merz","year":"2023","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.schres.2025.09.011_bb0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0004867419833166","article-title":"A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia","volume":"53","author":"Myles","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajhg.2007.09.003","article-title":"Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies","volume":"82","author":"Nalls","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2215-0366(23)00343-7","article-title":"Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study","volume":"11","author":"Northwood","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.011_bb0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3371\/CSRP.4.2.5","article-title":"Lithium to allow clozapine prescribing in benign ethnic neutropenia","volume":"4","author":"Nykiel","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"12","key":"10.1016\/j.schres.2025.09.011_bb0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","article-title":"The lifetime risk of suicide in schizophrenia: a reexamination","volume":"62","author":"Palmer","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2025.09.011_bb0205","article-title":"Mortality in schizophrenia-spectrum disorders: recent advances in understanding and management","volume":"10","author":"Peritogiannis","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.schres.2025.09.011_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpsychires.2022.11.017","article-title":"Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder","volume":"157","author":"Puangsri","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"959","key":"10.1016\/j.schres.2025.09.011_bb0215","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/pgmj.2004.031161","article-title":"Clozapine, agranulocytosis, and benign ethnic neutropenia","volume":"81","author":"Rajagopal","year":"2005","journal-title":"Postgrad. Med. J."},{"issue":"1\u20134","key":"10.1016\/j.schres.2025.09.011_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000528605","article-title":"Anti-inflammatory action of antidepressants: investigating the longitudinal effect of antidepressants on white blood cell count","volume":"9","author":"Sealock","year":"2023","journal-title":"Complex Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.011_bb0225","article-title":"Mixed-effects model: a useful statistical tool for longitudinal and cluster studies","volume":"49","author":"Silveira","year":"2023","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.schres.2025.09.011_bb0230","doi-asserted-by":"crossref","unstructured":"Siskind D, N.K., Pillinger T, Chan SKW, Correll CU, Cotes RO, Every-Palmer S, Hahn M, Howes O, Kane JM, Kelly DL, Korman N, Lappin J, Mena C, Myles N, McCutcheon R, A global Delphi guideline for absolute neutrophil count (ANC) and adverse drug reaction (ADR) monitoring during clozapine treatment. Lancet Psychiatry, 2025. (In Press).","DOI":"10.1016\/j.nsa.2025.105815"},{"key":"10.1016\/j.schres.2025.09.011_bb0235","series-title":"Clozapine for Treating Schizophrenia: A Comparison of the States","author":"Torrey","year":"2015"},{"issue":"3","key":"10.1016\/j.schres.2025.09.011_bb0240","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/schbul\/sbm111","article-title":"The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia","volume":"34","author":"Velligan","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0245","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur. Psychiatry"},{"issue":"10100","key":"10.1016\/j.schres.2025.09.011_bb0250","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.schres.2025.09.011_bb0255","article-title":"Generalized estimating equations in longitudinal data analysis: a review and recent developments","volume":"2014","author":"Wang","year":"2014","journal-title":"Adv. Statistics"},{"issue":"4","key":"10.1016\/j.schres.2025.09.011_bb0260","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s44220-025-00411-9","article-title":"The paradox of clozapine in black people with treatment-resistant schizophrenia","volume":"3","author":"Whiskey","year":"2025","journal-title":"Nat. Mental Health"},{"issue":"suppl_1","key":"10.1016\/j.schres.2025.09.011_bb0265","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/schbul\/sbx021.178","article-title":"120. Benign ethnic neutropenia in a sample of Nigerian healthy controls and clozapine-treated schizophrenia patients with DARC null variant","volume":"43","author":"Wonodi","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2025.09.011_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021040","article-title":"Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya","volume":"6","author":"Zeh","year":"2011","journal-title":"PLoS One"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425003214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425003214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:45:11Z","timestamp":1773110711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425003214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"alternative-id":["S0920996425003214"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.09.011","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}